CRISPR Therapeutics Company
Various next generation therapeutics, cancer, stem cells. Rapidly translating their specific, efficient and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes and other diseases.
Investors
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
1/1/2013
Employees Number:
101-250
Funding Status:
IPO
Total Funding:
127000000
Last Funding Type:
Grant
Register and Claim Ownership